Capital Investment Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$203K Buy
2,442
+1,145
+88% +$95K 0.02% 560
2025
Q1
$105K Hold
1,297
0.01% 605
2024
Q4
$117K Hold
1,297
0.01% 550
2024
Q3
$128K Sell
1,297
-1,333
-51% -$132K 0.01% 558
2024
Q2
$244K Sell
2,630
-4,406
-63% -$408K 0.03% 442
2024
Q1
$668K Sell
7,036
-2,183
-24% -$207K 0.07% 247
2023
Q4
$823K Sell
9,219
-11,385
-55% -$1.02M 0.08% 210
2023
Q3
$1.5M Buy
20,604
+584
+3% +$42.6K 0.15% 123
2023
Q2
$1.67M Sell
20,020
-1,314
-6% -$109K 0.16% 108
2023
Q1
$1.63M Sell
21,334
-1,876
-8% -$143K 0.19% 101
2022
Q4
$1.93M Sell
23,210
-282
-1% -$23.4K 0.23% 85
2022
Q3
$1.86M Sell
23,492
-5,361
-19% -$425K 0.24% 82
2022
Q2
$2.14M Buy
28,853
+17,589
+156% +$1.31M 0.26% 77
2022
Q1
$1.01M Buy
11,264
+2,804
+33% +$252K 0.11% 168
2021
Q4
$947K Buy
8,460
+618
+8% +$69.2K 0.11% 183
2021
Q3
$986K Buy
7,842
+2,609
+50% +$328K 0.12% 170
2021
Q2
$709K Buy
5,233
+2,465
+89% +$334K 0.09% 218
2021
Q1
$375K Buy
2,768
+1,018
+58% +$138K 0.05% 297
2020
Q4
$246K Hold
1,750
0.04% 375
2020
Q3
$195K Buy
1,750
+50
+3% +$5.57K 0.04% 364
2020
Q2
$190K Hold
1,700
0.04% 318
2020
Q1
$132K Buy
1,700
+38
+2% +$2.95K 0.03% 319
2019
Q4
$158K Buy
1,662
+1,162
+232% +$110K 0.04% 315
2019
Q3
$38K Hold
500
0.01% 632
2019
Q2
$43K Hold
500
0.01% 592
2019
Q1
$45K Sell
500
-475
-49% -$42.8K 0.02% 509
2018
Q4
$70K Sell
975
-1,258
-56% -$90.3K 0.03% 385
2018
Q3
$214K Sell
2,233
-358
-14% -$34.3K 0.1% 202
2018
Q2
$247K Buy
2,591
+189
+8% +$18K 0.12% 174
2018
Q1
$211K Buy
+2,402
New +$211K 0.12% 172